– FRANCE, Paris – BrightHeart, a company developing an AI solution for the prenatal detection of congenital heart defects, announced the appointment of Michael Butchko to its Board as an independent director, bringing more than 30 years of leadership experience and sectorial expertise to BrightHeart, along with a renowned reputation in the ultrasound space.…
– FRANCE, Montpellier – Sensorion (EPA: ALSEN), a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat, and prevent within the field of hearing loss disorders, today announced the appointment of Dr.…
– FRANCE, Paris – GenSight Biologics (EPA: SIGHT), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today announced the co-optation of CEO Laurence Rodriguez to its Board of Directors, replacing Bernard Gilly who resigned from the Board.…
– FRANCE, Puteaux – ORPEA (EPA: ORP) today announced the slate of candidates for their elections to its Board of Directors at the next AGM on 22 December 2023.
– FRANCE, Paris – Pernod Ricard (EPA: RI) today announced the appointment of Max Koeune to its Board of Directors, effective immediately.…
